Computer-Guided drug dosing shows promise for diabetic patients with liver disease

NCT ID NCT07439536

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether using a computer model to adjust doses of two common drugs (sitagliptin for diabetes and duloxetine for nerve pain) works better in people with liver cirrhosis. 64 patients with cirrhosis, diabetes, and nerve pain were grouped by liver severity and given personalized doses. Researchers measured blood sugar control and pain relief, while monitoring side effects and liver/kidney function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kafr El-Sheikh University

    Cairo, Kafrelsheikh, 33511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.